Cycrimine

Cycrimine (trade name Pagitane) is a central anticholinergic drug designed to reduce the levels of acetylcholine in the treatment of Parkinson's disease. Its mechanism of action is to bind to the muscarinic acetylcholine receptor M1.[1]

Cycrimine
Clinical data
License data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
ECHA InfoCard100.000.932
Chemical and physical data
FormulaC19H29NO
Molar mass287.447 g·mol−1
3D model (JSmol)

Synthesis

Cycrimine synthesis:[2]
gollark: That sounds kind of dangerous.
gollark: Spirit's already sort of a local meme.
gollark: If you want "somewhat cursed", how about this?
gollark: You should probably have a lot of backups.
gollark: That's cool. I would have expected you'd need some sort of digital circuitry to do that.

See also

References

  1. Psychotropic Drugs and Related Compounds, 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972, page 218
  2. Denton, J. J.; Schedl, H. P.; Lawson, Virginia A.; Neier, W. B. (1950). "Antispasmodics. VII.1 Additional Morpholinyl and Piperidyl Tertiary Alcohols". Journal of the American Chemical Society. 72 (8): 3795–3796. doi:10.1021/ja01164a127.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.